Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Total 13F shares
-
30,206,509
-
Share change
-
+1,060,580
-
Total reported value
-
$1,132,914,126
-
Put/Call ratio
-
26%
-
Price per share
-
$37.50
-
Number of holders
-
216
-
Value change
-
+$45,004,448
-
Number of buys
-
105
-
Number of sells
-
104
Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2023
As of 31 Mar 2023,
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by
216 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,206,509 shares.
The largest 10 holders included
BlackRock Inc., FEDERATED HERMES, INC., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, FULLER & THALER ASSET MANAGEMENT, INC., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Invesco Ltd., and Granite Investment Partners, LLC.
This page lists
216
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.